Skip to content
NewsBlazeAU – Lifestyle
Author:
Acadia Strategy Partners
Denteric Commences a Phase I Safety Study in Patients with Early Alzheimer’s Disease
May 28, 2026
Denteric Announces FDA IND Clearance for GPV381, a First-in-Class Therapeutic Vaccine Targeting Gingipain-Driven Inflammation in Periodontitis
March 24, 2026